Sodium Octanoate: Uses in Medicine, Food, and Drug Delivery

Sodium octanoate is the sodium salt of octanoic acid, an eight-carbon medium-chain fatty acid also known as caprylic acid. It turns up in a surprisingly wide range of settings, from the vials of albumin solution hanging in hospitals to breath tests that measure how quickly your stomach empties a meal. Its versatility stems from its chain length: short enough to dissolve easily in water, long enough to interact meaningfully with proteins and cell membranes, and metabolized by a pathway distinct from the longer-chain fats that dominate most dietary discussions.

How the Body Processes an Eight-Carbon Fat

Most dietary fats are long-chain fatty acids with sixteen or eighteen carbons. They require a complicated shuttle system involving carnitine to get into the mitochondria, where cells burn fuel. Octanoic acid, with only eight carbons, was long assumed to bypass that shuttle entirely and slip straight into mitochondria on its own. The reality is more nuanced and depends heavily on which tissue you are talking about.

Research comparing liver and muscle tissue has revealed a striking difference. Liver mitochondria readily oxidize free octanoate because they express high levels of medium-chain acyl-CoA synthetases, the enzymes needed to activate the molecule for burning. Heart and skeletal muscle mitochondria, by contrast, lack those enzymes and struggle to use free octanoate as fuel.¹ This finding has practical consequences: for patients with rare genetic disorders that block the long-chain fatty acid shuttle (like CPT2 deficiency), supplementing with medium-chain fats helps the liver but does not rescue the heart the way researchers once hoped.

In the liver, octanoate is strongly ketogenic. Classic perfusion experiments showed that adding octanoic acid to an isolated liver roughly doubled ketone body production when the dose was doubled, and that molecule for molecule, octanoic acid generates ketone bodies as effectively as palmitoleic acid, a long-chain fat.² This potent ketogenic effect is part of why medium-chain triglycerides (MCTs) are popular in ketogenic diets and why octanoate keeps surfacing in metabolic research.

Stabilizing Medicines and Cleaning Up Manufacturing

If you have ever received an intravenous albumin infusion, sodium octanoate was almost certainly in the solution. Commercial human serum albumin (HSA) preparations are heat-treated at 60 °C for 30 minutes to inactivate viruses, a process that would destroy the protein without stabilizers. Sodium octanoate is one of the key molecules added to prevent that damage. Studies using calorimetry and other structural techniques have confirmed that octanoate preserves the monomeric form of albumin during heating and raises its denaturation temperature.³

The mechanism is fairly intuitive once you picture the albumin molecule’s structure. Albumin has deep hydrophobic pockets known as drug-binding sites. Octanoate nestles into the largest of these cavities, in a subdomain called IIIA, essentially filling a void that would otherwise collapse or unfold under heat stress. Crystallographic work has confirmed this binding and shown that octanoate’s occupancy of that cavity directly accounts for the rise in thermal stability.⁴

Beyond albumin, caprylic acid (the protonated form of octanoate) plays a growing role in the purification of monoclonal antibodies, the engineered proteins behind many cancer and autoimmune drugs. The standard antibody purification process uses three chromatography columns, which is expensive and time-consuming. Researchers have shown that adding caprylic acid to the elution pool from the first column can precipitate out unwanted host-cell proteins and high-molecular-weight impurities, potentially eliminating an entire chromatography step. Key parameters like pH and caprylic acid concentration determine how effectively impurities are cleared, and under optimized conditions the process removes contaminants to acceptable levels while preserving the antibody.⁵ The broader potential of caprylic acid in antibody manufacturing, including its ability to simultaneously inactivate viruses and precipitate impurities, could simplify production lines for biologics.⁶

Virus inactivation is actually one of octanoate’s older pharmaceutical roles. Caprylate treatment of immunoglobulin solutions has been shown to rapidly inactivate enveloped viruses including HIV-1, bovine viral diarrhea virus, and pseudorabies virus. In head-to-head comparisons, caprylate inactivated some of these viruses twenty to sixty times faster than the standard solvent-detergent method, and its effectiveness was not diminished by high protein concentrations or different buffer compositions.⁷ For manufacturers of blood-derived therapies, this means a cheaper, faster step that may be easier to validate than older methods.

A Breath Test for Stomach Function

One of sodium octanoate’s most direct clinical uses has nothing to do with treatment. It is the tracer molecule in a widely used breath test that measures how quickly your stomach empties solid food. Here is how it works: a small amount of carbon-13-labeled sodium octanoate (written as ¹³C-sodium octanoate) is baked into a test meal, usually mixed into egg yolk. As the stomach digests the solid food and passes it into the small intestine, the labeled octanoate is absorbed, metabolized by the liver, and exhaled as ¹³CO₂. By measuring the ratio of ¹³CO₂ to normal CO₂ in the breath over time, clinicians can calculate how fast the stomach emptied without any radiation, tubes, or imaging.⁸

The test specifically tracks the solid phase of a meal. A companion tracer, ¹³C-acetate dissolved in water, tracks the liquid phase. Using both together in the same sitting lets researchers separate the emptying rates of solids and liquids, which can differ dramatically in certain conditions.⁹ Delayed gastric emptying (gastroparesis) is common in diabetes, Parkinson’s disease, and functional dyspepsia, and the octanoate breath test gives clinicians a noninvasive way to confirm and quantify it. Because the test is simple enough to repeat in a clinic setting, it is also used to monitor whether a drug is speeding up or slowing down stomach motility.

Activating the Hunger Hormone

Ghrelin is the peptide hormone your stomach secretes when it is empty, signaling your brain that it is time to eat. But raw ghrelin is actually inactive. To flip on, it needs to have an eight-carbon fatty acid chain attached to a specific amino acid residue. That attachment is performed by an enzyme called ghrelin O-acyltransferase, or GOAT, and the eight-carbon chain it attaches is octanoyl, derived from octanoic acid.¹⁰ Without dietary sources of medium-chain fatty acids to serve as substrates, the body cannot produce adequate active ghrelin.¹¹

This connection means that sodium octanoate is not just a bystander in metabolism; it is a direct precursor to an appetite-regulating signal. Animal studies have explored what happens when dietary octanoate levels change. In poultry research, for example, supplementing feed with sodium octanoate has been tested as a way to manipulate ghrelin levels and feeding behavior, with the broader goal of understanding whether medium-chain fat intake can be used to fine-tune appetite and growth in livestock.¹² For humans, the ghrelin link raises questions about how MCT-rich diets might influence hunger signaling beyond their well-known ketogenic effects, though clinical research specifically designed to test that question in people is still limited.

Emerging Research in Brain Injury and Tremor

Some of the most intriguing recent work with sodium octanoate involves the nervous system. In traumatic brain injury (TBI) models, researchers found that giving sodium octanoate shortly after injury enhanced mitochondrial respiration in the hippocampus within 24 hours, reduced the presence of inflammatory microglia at 48 hours, and decreased neurodegeneration by day three.¹³ The rationale is that injured brain tissue faces an energy crisis: its normal glucose-burning pathways are disrupted, and medium-chain fatty acids like octanoate can provide an alternative fuel. In a porcine model of cardiac arrest followed by resuscitation, sodium octanoate reduced oxidative stress and dampened a form of cell death called ferroptosis, offering some protection to both the heart and the brain.¹⁴

These are animal studies, so it would be premature to call sodium octanoate a treatment for human brain injuries. Still, the consistency of the signal across different injury models and species is generating genuine interest. The underlying idea, that boosting fatty acid oxidation can rescue cells whose other energy pathways have failed, is biologically plausible given what is known about how the brain shifts its fuel preferences after trauma.

Closer to clinical application is octanoic acid’s role in essential tremor, a common movement disorder that causes involuntary shaking, often of the hands or voice. Researchers have tested octanoic acid as a treatment for essential voice tremor and found that acoustic tremor severity was positively associated with treatment response, meaning people with worse tremor tended to benefit more. The data also suggested that the benefit accumulated over time, pointing to a cumulative effect of octanoic acid on the magnitude of tremor.¹⁵ The mechanism behind this tremor reduction is not entirely settled, but the finding is notable because essential tremor has limited treatment options and the available drugs carry significant side effects.

Fighting Fungi and Preserving Food

Caprylic acid has a long history as an antimicrobial agent, and its sodium salt shares those properties. In laboratory experiments targeting Candida albicans, caprylic acid damaged cell membranes and inhibited the efflux pumps that fungal cells use to expel antifungal compounds. When combined with plant-derived antifungals like carvacrol or thymol, the combinations achieved dramatic synergistic killing, because the membrane damage let the partner compounds flood in while the pump inhibition prevented the fungus from ejecting them.¹⁶

In food science, this antimicrobial activity translates into preservative potential. When tested against five common food-spoilage fungi in model low-acid, intermediate-moisture food systems (the kind of products where mold is a persistent problem), caprylic acid outperformed sorbic acid, the industry-standard preservative, at certain pH and water-activity levels.¹⁷ The fact that it works well under conditions relevant to real shelf-stable foods makes it a candidate for formulators looking for alternatives to traditional preservatives, particularly as consumer demand for “clean label” ingredients grows. Caprylic acid already appears on some food-additive lists as Generally Recognized as Safe (GRAS) in the United States.

Enhancing Drug Delivery Through Skin

Getting drugs to cross the skin barrier is a persistent challenge in pharmaceutical development. The outermost layer of skin, the stratum corneum, is a formidable wall of dead cells and lipids, and most drug molecules cannot get through it efficiently. Sodium caprylate (sodium octanoate) has shown ability to loosen that barrier. In experiments testing permeation enhancers for cromolyn sodium, a drug used to treat allergic and inflammatory conditions, sodium caprylate was the second most effective enhancer tested, behind sodium oleate.¹⁸ The mechanism likely involves the fatty acid chain intercalating between the lipids of the stratum corneum and temporarily increasing its fluidity, a process analogous to what sodium octanoate does to model membranes in biophysical research.

That biophysical work has shown directly that sodium octanoate lowers the phase transition temperature of lipid membranes in a concentration-dependent and linear fashion. The uncharged, protonated form of the molecule at lower pH is much more effective at disrupting membrane structure than the charged form at higher pH, which makes sense given that the uncharged molecule can more easily embed itself among the nonpolar lipid tails.¹⁹ For drug-delivery scientists, this pH dependence is useful: it means the permeation-enhancing effect can be tuned by adjusting the formulation’s pH.

A Tool for Separating Mirror-Image Molecules

A less well-known role for sodium octanoate lies in analytical chemistry, specifically in chiral separations. Many drug molecules exist as mirror-image pairs (enantiomers), and often only one version is therapeutically active while the other may be inert or even harmful. Separating them during quality control or development requires columns that can distinguish these subtly different shapes. Octanoate ions, when added to the mobile phase of a chromatography system using an alpha-1-acid glycoprotein column, improved the chiral separation of atropine, a drug used in ophthalmology and emergency medicine.²⁰ The effect was selective: it enhanced separation for atropine but suppressed it for the closely related molecule homatropine, which tells chemists something about how octanoate interacts with the protein-based stationary phase and alters the binding landscape for different drug structures. It is a niche application, but it illustrates how a single molecule’s physical properties can be leveraged across very different scientific domains.

Why One Molecule Keeps Showing Up Everywhere

The thread connecting all of these applications is octanoate’s position in a sweet spot of molecular size. At eight carbons, it is hydrophobic enough to interact with protein pockets, lipid membranes, and microbial cell walls, yet water-soluble enough (especially as the sodium salt) to be formulated easily in aqueous solutions, food matrices, and injectable medicines. Longer fatty acids are more hydrophobic and harder to work with in water. Shorter ones lack the hydrophobic reach to embed effectively in membranes or fill protein cavities. That Goldilocks quality is not a coincidence of one or two applications; it is the structural reason octanoate recurs across pharmacology, diagnostics, food technology, and basic biochemistry.

Regulatory familiarity adds to its appeal. Sodium octanoate and caprylic acid have been in use in pharmaceutical formulations for decades. Their safety profile in albumin stabilization is well established, their metabolic fate is understood, and their GRAS status in food contexts lowers the barrier for adoption in new applications. For researchers exploring novel uses, whether in neuroprotection after brain injury or cleaner antibody purification processes, starting from a molecule that regulators already know is a significant practical advantage over designing something new from scratch.